These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8671606)

  • 1. Monoclonal IgG as antigens: reduction is an early intracellular event of their processing by antigen-presenting cells.
    Santoro L; Reboul A; Kerblat I; Drouet C; Colomb MG
    Int Immunol; 1996 Feb; 8(2):211-9. PubMed ID: 8671606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells.
    Santoro L; Drouet C; Reboul A; Mach JP; Colomb MG
    Eur J Immunol; 1994 Jul; 24(7):1620-6. PubMed ID: 8026522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.
    Haque MA; Hawes JW; Blum JS
    J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin-specific T-B cell interaction. IV. B cell presentation of idiotypic determinant(s) of monoclonal anti-surface immunoglobulin antibody to idiotope-recognizing helper T clones.
    Rudensky AY; Mazel SM; Blechman JM; Yurin VL
    Eur J Immunol; 1990 Aug; 20(8):1691-6. PubMed ID: 2120062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule.
    Yurin VL; Rudensky AY; Mazel SM; Blechman JM
    Eur J Immunol; 1989 Sep; 19(9):1685-91. PubMed ID: 2507327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells.
    Vallé A; Garrone P; Yssel H; Bonnefoy JY; Freedman AS; Freeman G; Nadler LM; Banchereau J
    Immunology; 1990 Apr; 69(4):531-5. PubMed ID: 2335374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed isotype class II antigen expression. A novel class II molecule is expressed on a murine B cell lymphoma.
    Spencer JS; Kubo RT
    J Exp Med; 1989 Mar; 169(3):625-40. PubMed ID: 2647893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
    Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
    Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major involvement of cathepsin B in the intracellular proteolytic processing of exogenous IgGs in U937 cells.
    Santoro L; Reboul A; Journet AM; Colomb MG
    Mol Immunol; 1993 Aug; 30(11):1033-9. PubMed ID: 8350873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target.
    Schjetne KW; Thompson KM; Nilsen N; Flo TH; Fleckenstein B; Iversen JG; Espevik T; Bogen B
    J Immunol; 2003 Jul; 171(1):32-6. PubMed ID: 12816980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H; Berzofsky JA
    J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin-specific T-B cell interaction. I. Presentation of self immunoglobulin determinants by B lymphocytes.
    Rudensky AY; Yurin VL
    Eur J Immunol; 1989 Sep; 19(9):1677-83. PubMed ID: 2477255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
    Casten LA; Pierce SK
    J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
    Brazil MI; Weiss S; Stockinger B
    Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.
    Thornton BP; Vetvicka V; Ross GD
    Clin Exp Immunol; 1996 Jun; 104(3):531-7. PubMed ID: 9099940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.